Neuroimaging and CSF Biomarker Program
Funder
Alzheimer’s Drug Discovery Foundation
LOI Deadline
LOI Required
Yes
Application Deadline
Maximum Project Duration
1 years
Research Focus Areas
Biomarkers
Alzheimer’s Disease, Dementia, and Neurocognitive Disorders
Neurobiology/Neuroscience
Population Focus
Older Adults
Research Methods
Magnetic Resonance Imaging (MRI)/Other Imaging
Description
The aim of this RFP is to further develop and validate established biomarkers for which there is a clear clinical need in Alzheimer's disease and related dementias. This RFP prioritizes biomarkers with a defined context of use, a clear advantage over other relevant biomarkers, and a path to commercialization and/or clinical use